These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9275495)

  • 21. Long-term correction of rat model of Parkinson's disease by gene therapy.
    Jiao S; Gurevich V; Wolff JA
    Nature; 1993 Apr; 362(6419):450-3. PubMed ID: 8096625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protective effects of doxycycline upon dopaminergic neuron in LPS-induced rat model of Parkinson's disease].
    Wang PQ; Sun SG; Qiao X
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1346-50. PubMed ID: 19615192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic differentiation of human neural stem cells mediated by co-cultured rat striatal brain slices.
    Anwar MR; Andreasen CM; Lippert SK; Zimmer J; Martinez-Serrano A; Meyer M
    J Neurochem; 2008 Apr; 105(2):460-70. PubMed ID: 18194213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
    Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
    Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease.
    Shukla S; Agrawal AK; Chaturvedi RK; Seth K; Srivastava N; Sinha C; Shukla Y; Khanna VK; Seth PK
    J Neurochem; 2004 Oct; 91(2):274-84. PubMed ID: 15447661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cotransduction of tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes into cultured striatal cells using adeno-associated virus vectors.
    Fan D; Kang D; Ogawa M; Nakano I; Nagatsu T; Kurtzman GJ; Ozawa K
    Chin Med J (Engl); 1998 Dec; 111(12):1111-3. PubMed ID: 11263376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
    Wang L; Muramatsu S; Lu Y; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Hanazono Y; Kume A; Urano F; Ichinose H; Nagatsu T; Nakano I; Ozawa K
    Gene Ther; 2002 Mar; 9(6):381-9. PubMed ID: 11960314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alternation of proteins in brain of Parkinson's disease model rats after the transplantation of TH-NTN gene modified bone marrow mesenchymal stem cells].
    Huang Y; Chang C; Zhang JW; Gao XQ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(33):2353-6. PubMed ID: 23158567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells.
    Agrawal AK; Shukla S; Chaturvedi RK; Seth K; Srivastava N; Ahmad A; Seth PK
    Neurobiol Dis; 2004 Aug; 16(3):516-26. PubMed ID: 15262263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I; Kehr J; Andbjer B; Fuxe K
    Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
    St-Hilaire M; Landry E; Lévesque D; Rouillard C
    Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of foreign tyrosine hydroxylase gene in the rat model of Parkinson's disease].
    Jiang ZH; Ni ZM; Zhou CF; Cao L; Zheng ZC; Liu XY; Zhao YC; Chen SD
    Sheng Li Xue Bao; 1997 Apr; 49(2):141-5. PubMed ID: 9812848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term therapeutic effects on parkinsonian rats of intrastriatal co-grafts with genetically engineered fibroblasts expressing tyrosine hydroxylase and glial cell line-derived neurotrophic factor.
    Jingzhong Z; Hui Y; Deyi D; Chunli D; Chunli Z; Xiaohong S; Jinlu Z; Qunyuan X
    Int J Neurosci; 2005 Jun; 115(6):769-79. PubMed ID: 16019573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
    Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
    Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
    Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.